United Kingdom-Newcastle Upon Tyne: CON/217/RX4 = Supply of COBALT Drug Trial Requirements

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2021/S 000-016111/EN)
Nature of contract: Supply contract
Procedure: Open procedure
Type of bid required: Global bid

Contract notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Postal address: St Nicholas Hospital, Jubilee Road
Town: Newcastle Upon Tyne
Postal code: NE3 3XT
Country: United Kingdom
Contact Person: Mr Leigh Tidyman
Telephone: +44 1912467214
Email: leigh.tidyman@ntw.nhs.uk
Internet address(es):
Main address:
Address of the buyer profile:

I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge,at:
Additional information can be obtained from:
the above mentioned address
Tenders or requests to participate must be submitted:
electronically via:
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: CON/217/RX4 = Supply of COBALT Drug Trial Requirements

Reference number: DN555498
II.1.2) Main CPV code: 33600000
II.1.3) Type of contract: Supplies
II.1.4) Short Description: Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust are seeking expressions of interest from capable bidders for the following opportunity:
COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)
Introduction
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW) and The University of Melbourne (UoM), Australia have successfully bid for funding to run 2 National, multi-site, placebo controlled clinical trial assessing if adjunctive Memantine use in patients with Lewy Body Dementia (LBD) and Parkinson’s Disease Dementia (PDD) has any effect on Clinical Global Impression (CGI) after 6 or 12 months. One trial will be based in the UK and sponsored by CNTW NHS FT and the second trial will be sponsored and run in Australia by The University of Melbourne (UoM). Both trials will run at the same time, use the same protocol, trial management and Investigational Medicinal Product (IMP). The trial will require active treatment with Memantine 5mg and 10mg tablets for a period of 12 months and the manufacture of a matching placebo 5mg and 10mg tablets.
The trial will be run in the UK by the Dementia Research Team at Newcastle Biomedical Research Centre and sponsored by CNTW NHS FT.
Full details of the opportunity can be found in the tender documents. To access these documents please ‘express an interest’ via the tender portal link detailed on this page.

II.1.6) Information about lots:
The contract is divided into lots: no
II.2) Description
II.2.3) Place of performance
Nuts code:
II.2.4) Description of the procurement:
See II.1.4. Short description and Tender documents for further detail.
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Duration in months: 54
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure:
Open procedureIV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 2021-08-10 Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted:EN
IV.2.7) Conditions for opening tenders
Date: 2021-08-10 Local time: 12:00

Section VI: Complementary information
VI.1) Information about recurrence:
This is a recurrent procurement: no
VI.2) Information about electronic workflows
VI.4) Procedures for review
VI.4.1) Review body
Official name: Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Town: Newcastle Upon Tyne
Country: United Kingdom
E-mail: leigh.tidyman@ntw.nhs.uk
VI.5) Date of dispatch of this notice:2021-07-09